AI IN MEDICINE

Daniel G. Aaron, MD, JD; Christopher Robertson, JD, PhD

In January 2026, Utah announced a partnership with an AI company to create a system that conducts comprehensive medical assessments and prescribes medications, initially focusing on prescription renewals. The software is designed to prescribe nearly 200 drugs, including corticosteroids and antidepressants. This document discusses the potential benefits and risks of AI prescribing, the role of the FDA, and the implications for public health and medical practice. It highlights the challenges of integrating AI into healthcare, particularly concerning regulatory oversight and the need for evidence of safety and effectiveness.